- Positive effect of palmitoylethanolamide and luteolin supplementation in the management of post-COVID-19 olfactory disorders
SARS-CoV-2 infection can leave long-term impacts on patients’ quality of life such as smell disorders. This multicenter, randomized, double-blind, placebo-controlled study examined the effect of palmitoylethanolamide and luteolin (PEA-LUT) supplementation combined with olfactory training in 185 subjects with a prior history of COVID-19 and persistent olfactory impairment. Treatment consisted in oral supplementation with placebo or ...
- N-acteylcysteine may reduce fertility disorders in men after a COVID-19 infection
COVID-19 may affect male fertility through virus division, cytotoxic effects on testicular tissue and immunopathological effect. This randomized, controlled, clinical study conducted in 200 men who experienced COVID-19 infection, has evaluated the effects of N-acetyl-cystein (NAC) supplementation on semen parameters.
The subjects took NAC 600 mg/day during 3 months. Results showed that subjects who got COVID-19 ...
- Review: use of Nigella sativa along with exercise training to prophylaxis and treatment COVID-19
COVID-19 has been recognized as pandemic by the world health organization (WHO) since March 11, 2020. COVID-19 causes inflammation in the lung tissue, which is usually accompanied by symptoms such as dry cough, chest pain, fever, and difficulty breathing. Simultaneously with the involvement of lung tissue, the immune system usually reacts to fight the virus. ...
- Efficacy of Brazilian green propolis (EPP-AF®) as an adjunct treatment for hospitalized COVID-19 patients
This randomized, controlled, open-label, single-center trial was conducted on 124 patients with COVID-19 receiving either 0, 400 or 800 mg/day EPP-AF® brazilian green propolis for 28 days. All participants received standard care including all necessary interventions, as determined by physician.
Results indicate that the length of hospital stay post-intervention was shorter in both propolis groups (6 ...
- Oral intake of curcumin with piperine reduce the morbidity and mortality in COVID-19 patients: a randomized controlled trial
This double-blind, randomized and controlled trial aimed to determine the effects of curcumin administered with piperine (to optimize absorption) on symptoms of patients with COVID-19 in addition to conventional treatment. Subjects received curcumin (525 mg) with piperine (2.5 mg) in tablet form (intervention group) or probiotics (control group) twice a day. Results revealed that curcumin ...
- Virgin coconut oil is effective in lowering C-reactive protein levels among suspect cases of COVID-19
This 28-day randomized, double-blind and controlled trial aimed to determine whether virgin coconut oil (VCO) could be used as an adjunct prophylaxis to prevent the progression of symptoms among suspect or probable cases of COVID-19 (n = 63 adults) in isolation facilities. The participants received either a standardized meal (control) or a standardized meal mixed ...
- Dietary supplements have modest but significant effects on COVID-19 infections
Food supplements can be included in the various approaches for the management of COVID-19 infections. However, evidences are scarce, and this study investigated the potential preventive effects of food supplements on COVID-19 infections.
445850 subscribers of an app aiming to self-report information related to COVID-19 have been followed.
Results showed that in participants from UK (372720 subjects), ...
- Interest of botanicals for COVID-19
Nutritional supplements, TaibUVID (each dose contained 2g nigella sativa, 1g chamomile and 10 ml natural honey) and TaibUVID Forte (adds 1g fennel, 0.5 gram costus, 0.5 gram senna to TaibUVID), were suggested as a adjuvants for COVID-19 contacts, patients and public prophylaxis. A retrospective study was conducted in Egypt (n=20). 65% of COVID-19 patients (n ...
- Neem (Azadirachta indica) may reduce the risk of COVID-19 infection
This pilot study, double-blinded, placebo-controlled and randomized, examined the prophylactic effect of neem in patients at risk of COVID-19 infection due to contact with COVID-19 positive patients. 190 participants have been enrolled. They received a placebo or 50 mg twice daily of a neem leaf extract for 28 days.
Among the 154 participants who completed the ...
- Omega 3 fatty acids in patients infected by COVID-19
In this double-blind, randomized clinical trial, 128 critically ill patients (35-85 years) infected with COVID-19 have been randomly assigned to the intervention (fortified formula with omega 3 fatty acids) (n = 42) and control (n = 86) groups during 14 days. The intervention group received one capsule of 1000 mg omega-3 daily containing 400 mg ...
